Back
Alnylam Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
ALNY
Alnylam Pharmaceuticals
Last Price:
$236.26
Seasonality Move:
0.32%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
Alnylam Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 241.86 | Sell |
| 20-day SMA: | 247.71 | Sell |
| 50-day SMA: | 260.72 | Sell |
| 200-day SMA: | 222.31 | Buy |
| 8-day EMA: | 242.39 | Sell |
| 20-day EMA: | 246.64 | Sell |
| 50-day EMA: | 254.33 | Sell |
| 200-day EMA: | 234.52 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.87 | Sell |
| Relative Strength Index (14 RSI): | 37.47 | Sell |
| Chaikin Money Flow: | -246312 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (242.44 - 253.88) | Sell |
| Bollinger Bands (100): | (249.75 - 280.91) | Sell |
Alnylam Pharmaceuticals Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 237.97 while ALNY 8-day simple moving average is 241.86, which is a Sell signal.
-
The stock price of ALNY is 237.97 while Alnylam Pharmaceuticals 20-day SMA is 247.71, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day simple moving average is 260.72 while ALNY share price is 237.97, making it a Sell technically.
-
ALNY stock price is 237.97 and Alnylam Pharmaceuticals 200-day simple moving average is 222.31, creating a Buy signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
25
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a SellThe current Alnylam Pharmaceuticals [ALNY] share price is $237.97. The Score for ALNY is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
30.7B
Price in USD:
237.97
Share Volume:
330.1K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
25
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 237.97 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 237.97 while ALNY 8-day exponential moving average is 242.39, which is a Sell signal.
-
The stock price of ALNY is 237.97 while Alnylam Pharmaceuticals 20-day EMA is 246.64, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 254.33 while ALNY share price is 237.97, making it a Sell technically.
-
ALNY stock price is 237.97 and Alnylam Pharmaceuticals 200-day simple moving average is 234.52, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is -4.87, suggesting Alnylam Pharmaceuticals is a Sell
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 37.47, which suggest Alnylam Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (242.44 - 253.88), which suggest Alnylam Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (249.75 - 280.91), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.